fda approves astrazeneca's thyroid cancer drug
the u.s. health regulator on wednesday approved astrazeneca plc's medullary thyroid cancer drug, vandetanib, the first treatment to be approved for the rare form of cancer.
http://feeds.reuters.com/~r/reuters/healthnews/~3/pf1nszvswvq/us-astrazeneca-idustre7356xt20110406
3619
06 Apr 2011 22:30:18
reuters
health